Correction: Synergistic effects of nab-PTX and anti-PD-1 antibody combination against lung cancer by regulating Pi3K/AKT pathway through the Serpinc1 gene
Abstract
Corrigendum on: Zhang J, Tang Z, Guo X, Wang Y, Zhou Y and Cai W (2022) Synergistic effects of nab-PTX and anti-PD-1 antibody combination against lung cancer by regulating the Pi3K/AKT pathway through the Serpinc1 gene. Front. Oncol. 12:933646. doi: 10.3389/fonc.2022.933646In the published article, there was an error in the Funding statement. The original text is "This work was supported by grant from the National Natural Science Foundation of China [Grant No. 8217130423].", but the correct funding number should be 82173892.When we were concluding the fund project, we found that the funding number marked on the published article was mistakenly the project's acceptance number instead of the correct approval number. The correct Funding statement appears below.
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Lung Cancer Treatments and Mutations
PI3K/AKT/mTOR signaling in cancer
Publication details
- Journal / source
- Frontiers in Oncology
- Volume
- 16
- Pages
- 1815252–1815252
- Publication date
- 3 March 2026
- Language
- EN